| Gene symbol | CD5 | Synonyms | LEU1, T1 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD5 molecule | ||||
| GTO ID | GTC3144 |
| Trial ID | NCT05487495 |
| Disease | T-Cell Acute Lymphoblastic Leukemia/Lymphoma |
| Altered gene | CD5 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CT125B |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Donor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/Lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | Beijing Boren Hospital |
| Other ID(s) | BRYY-IIT-LCYJ-2022-026 |
| Cohort 1 | |||||||||||
|
|||||||||||